TEMOkids Study : A Phase I Pediatric Study for KIMOZO, Oral Suspension of Temozolomide

NCT04610736 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Pediatric Cancer

Interventions

DRUG: Temozolomide Oral Suspension

Sponsor

Orphelia Pharma

Collaborators

[object Object]